FUTURE RECEIPTS SALE AND PURCHASE AGREEMENTFuture Receipts Sale and Purchase Agreement • April 27th, 2023 • Cannabis Bioscience International Holdings, Inc. • Services-commercial physical & biological research • New York
This agreement (this “Agreement”), dated 4/20/2023, between CLOUDFUND LLC (“Buyer”) and the seller(s) listed herein (collectively, the "Seller”) (all capitalized terms shall have the meanings ascribed to them below):
MASTER RESEARCH SERVICES AGREEMENTMaster Research Services Agreement • April 27th, 2023 • Cannabis Bioscience International Holdings, Inc. • Services-commercial physical & biological research
This Master Research Services Agreement ("Agreement") is entered into as of the date of last signature hereto (the "Effective Date") by and between:
ContractClinical Trial Agreement • April 27th, 2023 • Cannabis Bioscience International Holdings, Inc. • Services-commercial physical & biological research
CLINICAL TRIAL AGREEMENT This CLINICAL TRIAL AGREEMENT (the "Agreement") is effective August 19 th , 2022 (the "Effective Date"), by and between ALPHA RESEARCH INSTITUTE, LLC . located at 6201 Bonhomme Road, Suite 460 S, Houston Texas 77036 (the "Institution") on behalf of itself and its employee NICOLA ABATE, M . D . located at 4002 Garth Rd . Ste . 120 , Baytown, Texas 77521 ("Investigator") and PHARMACEUTICAL RESEARCH ASSOCIATES, INC . , a Virginia corporation, located at 4130 Parklake Avenue, Suite 400 , Raleigh, NC 27612 ("PRA") . Institution and the Investigator may be collectively referred to as the "Site". Pre a mble a. PR A has been engaged by Inventiva S . A . (the "Sponsor") to arrange, monitor, oversee and perfonn or haveperformed, on behalfof Sponsor, a multi - center Phase ill clinical trial(as d e fin e d below) funded by Sponsor to determine the safety and efficacy of Sponsor's Product (as defmed herein) in theindication of Non - Alcoholic SteatoHepatitis ("NASH") ; b.
FUTURE RECEIVABLES SALE AND PURCHASE AGREEMENTFuture Receivables Sale and Purchase Agreement • April 27th, 2023 • Cannabis Bioscience International Holdings, Inc. • Services-commercial physical & biological research • New York
This agreement (this “Agreement”), dated 3/30/2023, between AMERIFUND GROUP LLC (“Buyer”) and the seller(s) listed herein (collectively, the "Seller”) (all capitalized terms shall have the meanings ascribed to them below):
THIRD AMENDMENT TO OFFICE LEASEOffice Lease • April 27th, 2023 • Cannabis Bioscience International Holdings, Inc. • Services-commercial physical & biological research
This Third Amendment to Office Lease (this “Third Amendment”) is made and entered into by and between Precision Research Institute, LLC (“Tenant”), and 6201 Bonhomme, LP (“Landlord”), to be dated on and as of the date on which the Landlord executes this Third Amendment (the “Effective Date”).
